Gastrointestinal differentiation marker Cytokeratin 20 is regulated by homeobox gene CDX1.

Gastrointestinal differentiation marker Cytokeratin 20 is regulated by homeobox gene CDX1.

CDX1 is a transcription factor that plays a key role in intestinal development and differentiation. However, the downstream targets of CDX1 are less well defined than those of its close homologue, CDX2. We report here the identification of downstream targets of CDX1 using microarray gene-expression...

ver descrição completa

Detalhes bibliográficos
Main Authors:	Chan, C, Wong, N, Liu, Y, Bicknell, D, Turley, H, Hollins, L, Miller, C, Wilding, J, Bodmer, W
Formato:	Journal article
Idioma:	English
Publicado em:	2009

Registos relacionados

The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody
Por: Bayrak Reyhan, et al.
Publicado em: (2012-01-01)

Loss of CDX1 expression in colorectal carcinoma: promoter methylation, mutation, and loss of heterozygosity analyses of 37 cell lines.
Por: Wong, N, et al.
Publicado em: (2004)

Human Homeobox TGIFLX Regulates CDX1, CDX2, and OCT1 Genes Expression in Colorectal Cancer Cell Lines
Por: Soroosh Shahryarhesami, et al.
Publicado em: (2022-04-01)

CDX1 is an important molecular mediator of Barrett's metaplasia.
Por: Wong, N, et al.
Publicado em: (2005)

Cytokeratin 20-positive hepatocellular carcinoma
Por: G. Faa, et al.
Publicado em: (2009-12-01)

Cytokeratin 20-positive hepatocellular carcinoma
Por: D. Fanni, et al.
Publicado em: (2009-12-01)

Cytokeratin 7 negative and cytokeratin 20 positive orbital metastatic breast carcinoma
Por: Sabrina Bergeron, MSc, et al.
Publicado em: (2018-06-01)

Immunohistochemical Studies of Cytokeratins and Differentiation Markers in Bovine Ocular Squamous Cell Carcinoma
Por: Helena Vala, et al.
Publicado em: (2020-05-01)

p53 and cytokeratin 20 immune marker expression as dual marker in papillary lesions of urinary bladder
Por: Anita P. Javalgi, et al.
Publicado em: (2024-04-01)

Immunohistochemical staining of cytokeratin 20 and cytokeratin 7 in colorectal carcinomas: Four different immunostaining profiles
Por: Jaudah Al-Maghrabi, et al.
Publicado em: (2018-01-01)

Importance of cytokeratin-20 expression in papillary urothelial neoplasia
Por: İbrahim Karabulut, et al.
Publicado em: (2020-12-01)

Cdx1 and Cdx2 exhibit transcriptional specificity in the intestine.
Por: Stephanie Grainger, et al.
Publicado em: (2013-01-01)

Tumor budding in colorectal adenocarcinoma using cytokeratin 20 immunostaining
Por: Chaitra N, et al.
Publicado em: (2023-12-01)

CDX2 mutations do not account for juvenile polyposis or Peutz-Jeghers syndrome and occur infrequently in sporadic colorectal cancers.
Por: Woodford-Richens, K, et al.
Publicado em: (2001)

CDX2 mutations do not account for juvenile polyposis or Peutz-Jeghers syndrome and occur infrequently in sporadic colorectal cancers
Por: Woodford-Richens, K, et al.
Publicado em: (2001)

Biological significance of GATA3, cytokeratin 20, cytokeratin 5/6 and p53 expression in muscle-invasive bladder cancer.
Por: Chung-Chieh Wang, et al.
Publicado em: (2019-01-01)

Significance of Tumour Budding with Case Series Cytokeratin 20 Immunostaining as a Histopathological Prognostic Marker in Colorectal Adenocarcinoma
Por: Munireddy Swathi, et al.
Publicado em: (2019-01-01)

Combined immunohistochemistry of β-catenin, cytokeratin 7, and cytokeratin 20 is useful in discriminating primary lung adenocarcinomas from metastatic colorectal cancer
Por: Tokumoto Noriaki, et al.
Publicado em: (2006-02-01)

Immunohistochemical Expression of CDX2 in Gastroesophageal Junction Biopsies: An Emerging Marker for Early Intestinal Differentiation of Barrett’s Metaplasia
Por: Twisha Adhikari, et al.
Publicado em: (2022-04-01)

CDX2 Expression in ovarian teratomatous cells with intestinal differentiation
Por: M. Mora, et al.
Publicado em: (2006-01-01)

Imaging features of mucinous carcinoma arising from mature teratoma showing cytokeratin 7+ and cytokeratin 20+ expression profile: A case report
Por: Natsuko Atsukawa, MD, et al.
Publicado em: (2024-04-01)

The role of SATB2, CDX2, CK7 and CK20 in differentiating primary versus metastatic ovarian carcinoma
Por: Sana Tahir, et al.
Publicado em: (2024-09-01)

The use of Cytokeratin 19 (CK19) immunohistochemistry in lesions of the pancreas, gastrointestinal tract, and liver.
Por: Jain, R, et al.
Publicado em: (2010)

Expression and Clinical Significance of Cytokeratin-19 and Thymidine Kinase-1 in Advanced Gastrointestinal Cancer
Por: Ying-Ying Du, et al.
Publicado em: (2016-01-01)

Cytokeratins : advances in oncology /
Por: Temple, Amy, editor
Publicado em: (2015)

GenCDX / [cakera padat]
Por: 397147 Klug, William S., et al.
Publicado em: (2000)

Cytokeratin 17: An Adjunct Immunohistochemical Marker of Invasion in Squamous Neoplastic Skin Lesions
Por: Cem Leblebici
Publicado em: (2017-09-01)

Expression of cytokeratins 8 and 17 as a diagnostic marker of cervical intraepithelial neoplasia
Por: Kalodimos George, et al.
Publicado em: (2010-01-01)

Serum Cytokeratin 18 as a Metastatic and Therapeutic Marker for Extramammary Paget’s Disease
Por: Mariko Urano-Takaoka, et al.
Publicado em: (2022-01-01)

Selective activation of tumor growth-promoting Ca<sup>2+ </sup>channel MS4A12 in colon cancer by caudal type homeobox transcription factor CDX2
Por: Huber Christoph, et al.
Publicado em: (2009-09-01)

The Importance of Cytokeratin 19 Expression in the Differentiation of Basal Cell Carcinoma and Trichoepithelioma
Por: Recep Bedir, et al.
Publicado em: (2015-01-01)

N-Glycomic and Transcriptomic Changes Associated with CDX1 mRNA Expression in Colorectal Cancer Cell Lines
Por: Stephanie Holst, et al.
Publicado em: (2019-03-01)

Which urine marker test provides more diagnostic value in conjunction with standard cytology- ImmunoCyt/uCyt+ or Cytokeratin 20 expression
Por: Soyuer Serdar, et al.
Publicado em: (2009-06-01)

Differential expression level of cytokeratin 8 in cells of the bovine nucleus pulposus complicates the search for specific intervertebral disc cell markers.
Por: Gilson, A, et al.
Publicado em: (2010)

Clinicopathological Evaluation of Gall-Bladder Lesions in Cholecystectomy Specimens with Special Emphasis to Incidentally Detected Cases of Gall-Bladder Carcinoma Along with Immunohistochemical Study of Cytokeratin 7 and Cytokeratin 20
Por: Kakoli Bora, et al.
Publicado em: (2023-08-01)

Optimization of Cdx Transcription Factors Characteristics
Por: Javanbakht T.
Publicado em: (2023-08-01)

Anti-cytokeratin 7: a positive marker for epithelial dysplasia in flat bowel mucosa
Por: Svjetlana Radović, et al.
Publicado em: (2004-08-01)

Basal cytokeratin as a potential marker of low risk of invasion in ductal carcinoma in situ
Por: Fernando N. Aguiar, et al.
Publicado em: (2013-05-01)

Cdx2 regulates immune cell infiltration in the intestine
Por: Simon Chewchuk, et al.
Publicado em: (2021-08-01)

Clinicopathological features and the value of differential Cytokeratin 7 and 20 expression in resolving diagnostic dilemmas of ovarian involvement by colorectal adenocarcinoma and vice-versa
Por: Dikshit Rajesh, et al.
Publicado em: (2008-09-01)